Seattle, Wash. – January 8, 2018 – Stratos Genomics, Inc., a 4th generation DNA sequencing technology company, today announced it has raised $20 million in venture capital from Fisk Ventures. The funds will be used for final system development leading to commercial introduction of the company’s proprietary sequencing platform.

Stratos Genomics Announces Major Milestone: Sequencing with Expandable Nucleotides triggers $15,000,000 financing.

Stratos Genomics Inc. announced today it achieved a major technical milestone last month by demonstrating nanopore sequencing with their proprietary expandable nucleotides (X-NTP™).

Roche Invests in Stratos Genomics For Further Development of "Sequencing by Expansion" (SBX) Method

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today, it made a strategic investment in Stratos Genomics and entered into a research collaboration to support further development of their unique chemistry applied to single molecule sequencing of DNA fragments using protein nanopores.

GenomeWeb InSequence Feature, February 4

Stratos Genomics Working on Raising Funds to Move Sequencing-by-Expansion Technology to Market

by Julia Karow (reposted with permission from GenomeWeb)

Stratos Genomics Achieves Major Technical Milestone and Adds Tim Hunkapiller to Science Advisory Board

Seattle, Washington—February 20, 2013 – Stratos Genomics Inc today announced that it has reached its next significant milestone by achieving single molecule DNA sequencing of 100+ base templates with its patented “Sequencing by Expansion™” (SBX) technology. Stratos Genomics also announced the addition of Tim Hunkapiller, co-inventor of four-color Sanger sequencing, to its Science Advisory Board (SAB).

Stratos Genomics Receives $2 Million on Achievement of Sequencing Milestone

SEATTLE, WA—(Marketwire – Oct 9, 2012) – Stratos Genomics Inc today announced the closing of $2 million to support continued development and strategic discussions related to Stratos’ ultra low cost method of DNA sequencing called “Sequencing by Expansion™” (SBX™).
The funding follows the successful demonstration of single molecule DNA sequencing of 36 base templates by SBX this past June.

Stratos Genomics Receives Grant from the National Human Genome Research Institute for Further Development of Sequencing by Expansion Technology

Seattle, Wash. – August 23, 2011 – Stratos Genomics Inc. today announced receipt of grant funds from the National Human Genome Research Institute in the amount of $829,000 over two years. The NHGRI, part of the National Institutes of Health (NIH), awarded $14 million to nine qualifying research organizations on Monday, August 22, 2011, to support the development of revolutionary DNA sequencing technologies.

Stratos Genomics Announces Financing for Validation of SBX™ Genome Sequencing Technology

Seattle, Wash. – June 8, 2011 – Stratos Genomics Inc today announced $2.1 million of funding to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The funds are provided by existing shareholders as an “up round” to August 2010’s $4 million financing and under the same Series-A terms.

Stratos Genomics Receives Fundamental Patent on Sequencing by Expansion™ Technology

Seattle, Wash. – May 25, 2011 – Stratos Genomics Inc today announced it has been granted US Patent 7,939,259 titled “High Throughput Nucleic Acid Sequencing by Expansion.” Sequencing by Expansion™ (SBX™) is a method for converting DNA into a more easily-read polymer called an Xpandomer™. Xpandomers encode DNA base sequence information with high signal-to-noise reporters optimally positioned along the polymer chain. SBX is a solution to the intrinsic problem of sequencing native DNA at high-speed and low cost.